 | Merck asks EU regulator to authorize its COVID-19 pillEarlier this month, Britain became the first country in the world to OK the drug. The U.K. licensed molnupiravir for adults diagnosed with COVID-19 and with at least one risk factor for severe disease |
 | Tiny antibodies from llamas can potentially treat COVID-19: StudyResearchers at the Rosalind Franklin Institute in the UK found that nanobodies -- a smaller, simple form of antibody -- can effectively target the SARS-CoV-2 virus. |
 | Hetero's Tocilizumab biosimilar gets emergency use authorisation from DCGI for COVID treatmentHetero's biologics arm, Hetero Biopharma will manufacture the drug at its dedicated biologics facility, based at Jadcherla in Hyderabad. |
